ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Peels
|
9.4K |
2.7M |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9.4K
|
2.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Peels
|
380 |
125K |
19 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
380
|
125K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Peels
|
380 |
125K |
8 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
380
|
125K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Peels
|
362 |
116K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
116K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Peels
|
362 |
116K |
9 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
116K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial
|
|
Peels
|
362 |
116K |
8 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
362
|
116K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Peels
|
1.3K |
544K |
4 |
19/08/23 |
19/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
4
|
|
ASX - By Stock
|
MSB |
Would have, could have, should have…..3 years ago
|
|
Peels
|
0 |
242 |
3 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
0
|
242
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Peels
|
1.0K |
389K |
4 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Peels
|
1.0K |
389K |
18 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Peels
|
1.3K |
544K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
544K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Peels
|
39 |
18K |
9 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
39
|
18K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
1 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
8 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
9 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
9 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
7 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Peels
|
3.4K |
1.1M |
3 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
post approval sp guesstimate
|
|
Peels
|
168 |
54K |
16 |
12/06/23 |
12/06/23 |
ASX - By Stock
|
168
|
54K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Peels
|
274 |
119K |
6 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
274
|
119K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Peels
|
1.0K |
383K |
12 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
383K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
Peels
|
914 |
286K |
1 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
914
|
286K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
Peels
|
914 |
286K |
1 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
914
|
286K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Peels
|
618 |
234K |
3 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
618
|
234K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2023 - awaiting for Ryoncil approval
|
|
Peels
|
618 |
234K |
7 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
618
|
234K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
Peels
|
239 |
65K |
1 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
239
|
65K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
Peels
|
239 |
65K |
6 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
239
|
65K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
Peels
|
239 |
65K |
7 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
239
|
65K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Peels
|
1.0K |
322K |
15 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
1.0K
|
322K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
Peels
|
321 |
103K |
14 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
103K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
|
|
Peels
|
299 |
104K |
6 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
299
|
104K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
Peels
|
213 |
58K |
9 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
213
|
58K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Peels
|
505 |
160K |
13 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
505
|
160K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Peels
|
1.0K |
322K |
49 |
06/03/22 |
06/03/22 |
ASX - By Stock
|
1.0K
|
322K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Peels
|
4.7K |
1.0M |
10 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
4.7K
|
1.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Peels
|
1.1K |
319K |
2 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
1.1K
|
319K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
Peels
|
1.1K |
319K |
20 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
1.1K
|
319K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Peels
|
211 |
72K |
16 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
72K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Peels
|
10K |
3.0M |
14 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
14
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Peels
|
10K |
3.0M |
18 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Peels
|
850 |
249K |
19 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
249K
|
19
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Peels
|
10K |
3.0M |
20 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
20
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Peels
|
10K |
3.0M |
0 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Peels
|
10K |
3.0M |
21 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Peels
|
17K |
6.6M |
6 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
17K
|
6.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
Peels
|
953 |
288K |
19 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
953
|
288K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
Peels
|
953 |
288K |
26 |
06/11/21 |
06/11/21 |
ASX - By Stock
|
953
|
288K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Peels
|
17K |
6.6M |
3 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Peels
|
17K |
6.6M |
4 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Peels
|
17K |
6.6M |
5 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|